Bonito Biosciences

About Bonito Biosciences

This startup develops an oligo-based platform to create RNA degraders, utilizing cell-specific delivery technology. Their platform aims to provide targeted therapeutic solutions for patients by efficiently delivering RNA-degrading molecules.

This startup develops an oligo-based platform to create RNA degraders, utilizing cell-specific delivery technology. Their platform aims to provide targeted therapeutic solutions for patients by efficiently delivering RNA-degrading molecules.

What does Bonito Biosciences do?

This startup develops an oligo-based platform to create RNA degraders, utilizing cell-specific delivery technology. Their platform aims to provide targeted therapeutic solutions for patients by efficiently delivering RNA-degrading molecules.

Where is Bonito Biosciences located?

Bonito Biosciences is based in Waltham, United States.

How much funding has Bonito Biosciences raised?

Bonito Biosciences has raised 9000000.

Location
Waltham, United States
Funding
9000000
Employees
26 employees
Major Investors
Anterra Capital

Find Investable Startups and Competitors

Search thousands of startups using natural language

Bonito Biosciences

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

This startup develops an oligo-based platform to create RNA degraders, utilizing cell-specific delivery technology. Their platform aims to provide targeted therapeutic solutions for patients by efficiently delivering RNA-degrading molecules.

bonitobio.com2K+
cb
Crunchbase
Waltham, United States

Funding

$

Estimated Funding

$5M+

Major Investors

Anterra Capital

Team (25+)

No team information available.

Company Description

This startup develops an oligo-based platform to create RNA degraders, utilizing cell-specific delivery technology. Their platform aims to provide targeted therapeutic solutions for patients by efficiently delivering RNA-degrading molecules.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.